Document Details
Form
Filing Date
Mar 2, 2023
Document Date
Feb 28, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
HEGGIE THERESA